Bio-Techne

TECH • NASDAQ •
Overview Stats Financials News

Quarterly Financials

Values in thousands 2024-03-31 2023-12-31 2023-09-30 2023-06-30
Revenue $303,428 $272,598 $276,935 $301,320
Gross Profit 205,246 176,587 185,191 204,697
EBITDA 99,291 65,519 84,402 121,448
EBIT 71,980 37,716 55,862 94,525
Net Income 49,059 27,465 50,993 75,484
Net Change In Cash 303,428 272,598 276,935 301,320
Cost of Revenue 54,415
Free Cash Flow 64,545 68,252 45,791 72,562
Cash 139,915 130,132 148,663 180,571
Basic Shares 160,496 160,060 161,940 161,920

Annual Financials

Values in thousands 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Revenue $1,136,702 $1,105,599 $931,032 $738,691
Gross Profit 769,815 756,496 632,850 483,194
EBITDA 406,182 397,659 237,296 157,419
EBIT 298,944 296,590 149,549 74,682
Net Income 285,263 272,051 140,410 229,296
Net Change In Cash 1,136,702 1,105,599 931,032 738,691
Cost of Revenue 11,360 -14,432 46,097 48,510
Free Cash Flow 216,149 280,364 307,863 153,473
Cash 180,571 172,567 199,091 146,625
Basic Shares 161,855 164,116 161,932 157,604

Earnings Calls

Quarter EPS
2024-03-31 $0.48
2023-12-31 $0.40
2023-09-30 $0.41
2023-06-30 $0.55